The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Esophageal Motility Disorders

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Esophageal Motility Disorders

 

Psychiatry related information on Esophageal Motility Disorders

 

High impact information on Esophageal Motility Disorders

 

Chemical compound and disease context of Esophageal Motility Disorders

 

Anatomical context of Esophageal Motility Disorders

 

Gene context of Esophageal Motility Disorders

 

Analytical, diagnostic and therapeutic context of Esophageal Motility Disorders

  • Patients with MVP (13 female, one male; mean age 49 years) were more likely (P = 0.01) to have esophageal dysmotility, while acid perfusion was less likely (P < 0.05) to provoke their chest pain, than in patients without MVP [22].

References

  1. Tubulin interaction with kinetochore proteins: analysis by in vitro assembly and chemical cross-linking. Balczon, R.D., Brinkley, B.R. J. Cell Biol. (1987) [Pubmed]
  2. Globus sensation: pharyngoesophageal function, psychometric and psychiatric findings, and follow-up in 88 patients. Moser, G., Wenzel-Abatzi, T.A., Stelzeneder, M., Wenzel, T., Weber, U., Wiesnagrotzki, S., Schneider, C., Schima, W., Stacher-Janotta, G., Vacariu-Granser, G.V., Pokieser, P., Bergmann, H., Stacher, G. Arch. Intern. Med. (1998) [Pubmed]
  3. Association of 5'-untranslated region of the Fibrillin-1 gene with Japanese scleroderma. Kodera, T., Tan, F.K., Sasaki, T., Arnett, F.C., Bona, C.A. Gene (2002) [Pubmed]
  4. Diltiazem therapy for symptoms associated with nutcracker esophagus. Cattau, E.L., Castell, D.O., Johnson, D.A., Spurling, T.J., Hirszel, R., Chobanian, S.J., Richter, J.E. Am. J. Gastroenterol. (1991) [Pubmed]
  5. The role of gastroesophageal reflux in pediatric dysphagia. Catto-Smith, A.G., Machida, H., Butzner, J.D., Gall, D.G., Scott, R.B. J. Pediatr. Gastroenterol. Nutr. (1991) [Pubmed]
  6. Chest pain at rest in patients with coronary artery disease. Myocardial ischemia, esophageal dysfunction, or panic disorder? Ros, E., Armengol, X., Grande, L., Toledo-Pimentel, V., Lacima, G., Sanz, G. Dig. Dis. Sci. (1997) [Pubmed]
  7. Effects of nifedipine in achalasia and in patients with high-amplitude peristaltic esophageal contractions. Traube, M., Hongo, M., Magyar, L., McCallum, R.W. JAMA (1984) [Pubmed]
  8. Effect of isosorbide and hydralazine in painful primary esophageal motility disorders. Mellow, M.H. Gastroenterology (1982) [Pubmed]
  9. Verapamil--a potent inhibitor of esophageal contractions in the baboon. Richter, J.E., Sinar, D.R., Cordova, C.M., Castell, D.O. Gastroenterology (1982) [Pubmed]
  10. Provocation of esophageal pain by ergonovine or edrophonium. London, R.L., Ouyang, A., Snape, W.J., Goldberg, S., Hirshfeld, J.W., Cohen, S. Gastroenterology (1981) [Pubmed]
  11. Treatment of calcinosis with diltiazem. Palmieri, G.M., Sebes, J.I., Aelion, J.A., Moinuddin, M., Ray, M.W., Wood, G.C., Leventhal, M.R. Arthritis Rheum. (1995) [Pubmed]
  12. Current medical therapy for esophageal motility disorders. Achem, S.R., Kolts, B.E. Am. J. Med. (1992) [Pubmed]
  13. The esophagus after endoscopic injection sclerotherapy: acute and chronic changes. Agha, F.P. Radiology. (1984) [Pubmed]
  14. Cyclosporine A-induced achalasia-like esophageal motility disorder in a liver transplant recipient: successful conversion to tacrolimus. Koch, R., Zoller, H., Graziadei, I., Propst, A., Vogel, W. Transplantation (2003) [Pubmed]
  15. Esophageal motor disorder in alcoholics: result of alcoholism or withdrawal? Keshavarzian, A., Polepalle, C., Iber, F.L., Durkin, M. Alcohol. Clin. Exp. Res. (1990) [Pubmed]
  16. Procainamide-induced myasthenia-like weakness and dysphagia. Miller, C.D., Oleshansky, M.A., Gibson, K.F., Cantilena, L.R. Therapeutic drug monitoring. (1993) [Pubmed]
  17. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Lock, G., Pfeifer, M., Straub, R.H., Zeuner, M., Lang, B., Schölmerich, J., Holstege, A. Am. J. Gastroenterol. (1998) [Pubmed]
  18. Diagnosis of coronary vasospasm in patients with clinical presentation of unstable angina pectoris using ergonovine echocardiography. Song, J.K., Park, S.W., Kang, D.H., Lee, C.W., Choi, K.J., Hong, M.K., Kim, J.J., Kim, Y.H., Park, S.J. Am. J. Cardiol. (1998) [Pubmed]
  19. Esophageal dysmotility in brothers with an FG-like syndrome. Smith, R.L., Edwards, M.J., Notaras, E., O'Loughlin, E.V. Am. J. Med. Genet. (2000) [Pubmed]
  20. Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility. Montecucco, C., Caporali, R., Cobianchi, F., Negri, C., Astaldi-Ricotti, G.C. Clinical and experimental rheumatology. (1992) [Pubmed]
  21. Etiology of 19 infants with apparent life-threatening events: relationship between apnea and esophageal dysfunction. Tsukada, K., Kosuge, N., Hosokawa, M., Umezu, R., Murata, M. Acta paediatrica Japonica; Overseas edition. (1993) [Pubmed]
  22. Esophageal dysmotility and acid sensitivity in patients with mitral valve prolapse and chest pain. Hammett, R.J., Hansen, R.D., Lorang, M., Bak, Y.T., Kellow, J.E. Dis. Esophagus (2003) [Pubmed]
 
WikiGenes - Universities